Business / Finance

RSS

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

HealthSouth Corporation, a leading provider of post-acute healthcare services, today announced its Encompass Home Health business unit has completed its previously announced acquisition of the home health and hospice agency operations of CareSouth Health System, Inc.

2 Nov 2015

Xcelience announces grand opening of new headquarters in Tampa

Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other elected and non-elected officials.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Semler Scientific's revenue up 74% in third quarter 2015

Semler Scientific, Inc., a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.

30 Oct 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.

From Omnicell, Inc. 30 Oct 2015

Omnicell signs definitive agreement to acquire Aesynt

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced it has entered into a definitive agreement to acquire Aesynt Incorporated.

From Omnicell, Inc. 30 Oct 2015

Tandem Diabetes Care sales grow 16% to $15.7 million in third quarter 2015

Tandem Diabetes Care, Inc., a medical device company and manufacturer of the t:slim, t:flex and t:slim G4 Insulin Pumps, today reported its financial results for the quarter ended September 30, 2015.

30 Oct 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus' UNA Oligomer chemistry and LUNAR nanoparticle delivery platform.

29 Oct 2015

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

InComm, a leading prepaid product and transaction services company, and Pursuant Health (formerly SoloHealth) announced today a partnership to allow health plans to promote health risk assessments (HRAs) at Pursuant Health kiosks in Walmart stores. Health plans will be able to issue their members branded incentive cards with healthy rewards as part of the completion of the HRA.

27 Oct 2015

Galil Medical signs agreement to acquire 100% of Perseon

Galil Medical, the global leader in interventional oncology cryoablation technology, announced today it has entered into an agreement to acquire 100% of Perseon Corporation, a publicly-traded company and a leader in the field of microwave ablation, in an all cash transaction valued at $10.6M. The resulting combined company will be privately owned.

27 Oct 2015

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Ipsen and the US company EpiVax, Inc. today announced that they have completed a collaborative project that provides a novel approach for creating next generation botulinum neurotoxin (BoNT) and Targeted Secretion Inhibitor (TSI) therapeutics.

27 Oct 2015

Edwards Lifesciences' net sales grow 1.3% to $615.5 million in third quarter 2015

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported financial results for the quarter ended September 30, 2015.

27 Oct 2015

CareFusion, AAM Healthcare sign exclusive distribution agreement for APA video laryngoscope

CareFusion, a BD company, today announced its Vital Signs anesthesia delivery and patient monitoring business has entered into an exclusive agreement with AAM Healthcare to distribute its APA video laryngoscope in the U.S. and 12 other countries.

26 Oct 2015

Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

On Thursday, October 22, Frost & Sullivan honoured recipients of its 2015 Excellence in Best Practices Awards Banquet in Monaco. With a festive ambiance and exciting Awards, the event brought together top executives to celebrate their success.

23 Oct 2015

Quest Diagnostics announces net income of $342 million for third quarter of 2015

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the quarter ended September 30, 2015, adjusted net income was $172 million compared to $161 million for 2014. Adjusted diluted EPS excluding amortization was $1.28 in the third quarter of 2015, compared to $1.20 in 2014.

From Quest Diagnostics 22 Oct 2015

Adeptus Health's net operating revenue increases 53% to $88.2 million in third quarter 2015

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the third quarter ended September 30, 2015.

22 Oct 2015

Honeywell inks definitive agreement to acquire Sigma-Aldrich's laboratory research chemicals business

Honeywell (NYSE: HON) today announced that it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.

20 Oct 2015

Sigma-Aldrich, Sanger Institute partner to manufacture and distribute arrayed lentiviral CRISPR library

Sigma-Aldrich Corporation today announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's arrayed lentiviral CRISPR library. The library will be the first of its kind, providing researchers with a collection of individual clones designed to knock out every known human and mouse protein-coding gene using the CRISPR system.

20 Oct 2015

Allergan completes acquisition of AqueSys

Allergan plc, a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma.

19 Oct 2015

Business / Finance

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

Xcelience announces grand opening of new headquarters in Tampa

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Q BioMed signs definitive license agreement with Mannin Research

Semler Scientific's revenue up 74% in third quarter 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell signs definitive agreement to acquire Aesynt

Tandem Diabetes Care sales grow 16% to $15.7 million in third quarter 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

Galil Medical signs agreement to acquire 100% of Perseon

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Edwards Lifesciences' net sales grow 1.3% to $615.5 million in third quarter 2015

CareFusion, AAM Healthcare sign exclusive distribution agreement for APA video laryngoscope

Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

Quest Diagnostics announces net income of $342 million for third quarter of 2015

Adeptus Health's net operating revenue increases 53% to $88.2 million in third quarter 2015

Honeywell inks definitive agreement to acquire Sigma-Aldrich's laboratory research chemicals business

Sigma-Aldrich, Sanger Institute partner to manufacture and distribute arrayed lentiviral CRISPR library

Allergan completes acquisition of AqueSys

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News